Alphabet Inc. - Q4 2020 holdings

$2.08 Billion is the total value of Alphabet Inc.'s 33 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 45.8% .

 Value Shares↓ Weighting
LYFT SellLyft Inc$568,459,000
+60.8%
11,570,524
-9.8%
27.27%
+64.3%
DXCM  Dexcom Inc$297,876,000
-10.3%
805,6810.0%14.29%
-8.4%
DM NewDesktop Metal Inc.$246,002,00014,302,438
+100.0%
11.80%
TWLO NewTwilio Inccl a$161,078,000475,859
+100.0%
7.73%
RCUS  Arcus Biosciences Inc$131,092,000
+51.5%
5,049,7860.0%6.29%
+54.7%
ABNB NewAirbnb Inc$101,529,000691,612
+100.0%
4.87%
LMND  Lemonade Inc$101,031,000
+146.4%
824,7430.0%4.85%
+151.7%
RLAY  Relay Therapeutics Inc$74,870,000
-2.4%
1,801,4900.0%3.59%
-0.3%
WORK  Slack Technologies Inc.$54,902,000
+57.3%
1,299,7710.0%2.63%
+60.6%
BEAM  Beam Therapeutics Inc$54,184,000
+231.6%
663,6910.0%2.60%
+238.5%
KRON NewKronos Bio Inc$42,960,0001,438,232
+100.0%
2.06%
UPST NewUpstart Hldgs Inc$33,921,000832,423
+100.0%
1.63%
OPEN NewOpendoor Technologies Inc$28,435,0001,250,997
+100.0%
1.36%
MGTA  Magenta Therapeutics Inc$26,179,000
+15.3%
3,339,1380.0%1.26%
+17.7%
SQZ NewSQZ Biotechnologies Co$24,094,000831,389
+100.0%
1.16%
SPRO SellSpero Therapeutics Inc$17,257,000
+39.0%
889,979
-20.0%
0.83%
+42.0%
TSHA  Taysha Gene Therapies Inc$17,009,000
+18.5%
640,8820.0%0.82%
+21.1%
RAPT SellRAPT Therapeutics Inc$16,417,000
-39.0%
831,254
-0.6%
0.79%
-37.7%
EVLO  Evelo Biosciences Inc$12,821,000
+129.4%
1,060,4950.0%0.62%
+133.8%
IDYA  Ideaya Biosciences Inc$10,545,000
+11.5%
753,1870.0%0.51%
+14.0%
FHTX NewFoghorn Therapeutics Inc$10,153,000500,901
+100.0%
0.49%
MWK SellMohawk Group Hldgs Inc$10,091,000
+35.8%
586,327
-34.9%
0.48%
+38.7%
FULC  Fulcrum Therapeutics Inc$7,941,000
+47.7%
678,1410.0%0.38%
+50.6%
CRWD  Crowdstrike Hldgs Inccl a$6,571,000
+54.2%
31,0200.0%0.32%
+57.5%
AUTL  Autolus Therapeutics PLCspon ads$6,242,000
-23.2%
698,2620.0%0.30%
-21.7%
NEWR NewNew Relic Inc$5,960,00091,132
+100.0%
0.29%
CLDR  Cloudera Inc$5,949,000
+27.7%
427,7100.0%0.28%
+30.1%
CRTX  Cortexyme Inc$5,254,000
-44.4%
189,1220.0%0.25%
-43.2%
ALEC  Alector Inc$2,661,000
+43.6%
175,8660.0%0.13%
+47.1%
UBER BuyUber Technologies Inc$2,523,000
+66.3%
49,466
+19.0%
0.12%
+70.4%
DBX  Dropbox Inccl a$289,000
+15.1%
13,0330.0%0.01%
+16.7%
GRTS ExitGritstone Oncology Inc$0-547,488
-100.0%
-0.07%
JD ExitJD com Incspon adr cl a$0-13,553,474
-100.0%
-49.41%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-11-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
SPERO THERAPEUTICS INC24Q3 20233.5%
AUTOLUS THERAPEUTICS PLC22Q3 20232.8%
Magenta Therapeutics Inc.21Q2 20233.8%
DEXCOM INC20Q3 202317.4%
Evelo Biosciences Inc.20Q1 20231.6%
ALECTOR INC19Q3 20231.1%
Lyft Inc18Q2 202351.9%
QUINCE THERAPEUTICS INC18Q3 20230.6%
Arcus Biosciences Inc17Q1 202212.7%
FULCRUM THERAPEUTICS INC17Q3 20230.7%

View Alphabet Inc.'s complete holdings history.

Latest significant ownerships (13-D/G)
Alphabet Inc. Q4 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
ARRIS International plcFebruary 14, 20197,603,5004.4%

View Alphabet Inc.'s complete significant-ownership history.

Latest filings
TypeFiled
10-Q2024-04-26
1442024-04-26
42024-04-26
42024-04-26
ARS2024-04-26
DEF 14A2024-04-26
DEFA14A2024-04-26
8-K2024-04-25
1442024-04-17
1442024-04-17

View Alphabet Inc.'s complete filings history.

Compare quarters

Export Alphabet Inc.'s holdings